Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole dose comparison combined with HMG for ovulation induction in infertility associated with polycystic ovary syndrome
ChiCTR2100045832Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of letrozole and human menopausal gonadotrophin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Union Hospital. Primary endpoints: Ovulation rate, Total pregnancy rate and 1 more. Started May 2021; status: recruiting.
02
Drugs
letrozolehuman menopausal gonadotrophin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2100045832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045832.